CSS
NVO

Cubist Systematic Strategies’s Novo Nordisk NVO Stock Holding History

Cubist Systematic Strategies’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$216K Sell
3,900
-59,000
-94% -$3.45M ﹤0.01% 2627
2025
Q2 		$4.34M Buy
+62,900
New +$4.28M 0.02% 1100
2025
Q1 		– Sell
-2,300
Closed -$198K – 3318
2024
Q4 		$198K Buy
+2,300
New +$249K ﹤0.01% 2572
2024
Q1 		– Sell
-14,000
Closed -$1.45M – 4118
2023
Q4 		$1.45M Sell
14,000
-4,800
-26% -$475K 0.01% 1763
2023
Q3 		$1.71M Hold
18,800
– – 0.01% 1480
2023
Q2 		$1.52M Buy
+18,800
New +$1.54M 0.01% 1692

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cubist Systematic Strategies's NVO Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 216,596 shares — an estimated $27.8M sold.

Cubist Systematic Strategies first reported a position in NVO in Q2 2014 and held it in 37 quarters. The position peaked at $27.8M in Q1 2024. 1,866 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 216,596 Novo Nordisk shares in Q2 2024, an estimated $27.8M.
  • Cubist Systematic Strategies first reported a position in Novo Nordisk in Q2 2014 and held it in 37 quarters.
  • Cubist Systematic Strategies's Novo Nordisk position peaked at $27.8M in Q1 2024.
  • 1,866 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.